Reversal of GABA-mediated inhibition of the electrically and potassium chloride evoked [H-3]-GABA release from rat substantia nigra slices by DL-3-hydroxy-3-phenyl pentanamide

Medicine & Life Sciences

• DL-3-hydroxy-3-phenyl pentanamide 100%
• Potassium Chloride 48%
• pentigide 42%
• Substantia Nigra 41%
• gamma-Aminobutyric Acid 37%
• CGP 55845A 18%
• GABA-B Receptor Antagonists 10%
• 3-hydroxy-3-phenylpentamide 8%
• Baclofen 8%
• gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide 7%
• butyramide 6%
• caproamide 6%
• 3-aminobutyric acid 6%
• picrotoxinin 5%
• GABA Modulators 5%
• GABA-B Receptor Agonists 5%
• Tiagabine 5%
• Brain 4%
• Fluorine 4%
• GABA-A Receptor Antagonists 4%
• Chlorine 4%
• Synaptic Membranes 4%
• Bicuculline 3%
• GABA Receptors 3%
• Amides 3%
• GABA-A Receptors 3%
• Alcohols 2%
• Ligands 2%

Chemistry

• Pentanamide 71%
• Potassium Chloride 44%
• Agent Interacting With Transmitter, Hormone or Drug Receptor 43%
• GABA Modulator 28%
• 4 Aminobutyric Acid A Receptor Blocking Agent 23%
• Tiagabine 23%
• Picrotoxinin 21%
• Baclofen 19%
• Bicuculline 19%
• Fluorine Atom 11%
• Chlorine 11%
• Amide 9%
• Alcohol 7%
• Ligand 5%
• Acid 4%